ϸ°ûÉúÎïѧ£º z$7YC49^
Ò»¡¢ Ãû´Ê½âÊÍ£º x)"=
*Jj
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© E|97zc
2£® PCR£¨96£©
cD0
3£® ·ºËØ£¨ubquitin£©£¨96£© hp-<8Mf
4£® °é·Ö×Ó£¨chapron£©£¨96£© W:(:hT6`j9
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© |]GEJUWtCd
6£® DG£IP3£¨96£© 'Dat.@j
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© !ox &`
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© |o!<@/iH=
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© GGJ_,S*
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© jQb=N%5s
11£® Transformation£¨92£© UBqK$2
#
12£® TransfectionתȾ£¨92£© ]m4LY.SQ
13£® Transcytosis×ªÒÆ×÷Óã¨92£© bzJKoxU
14£® Transductionתµ¼£¨92£© s{s0#g
15£® Transdetermination£¨92£© $hKgTf?
16£® Transdifferentiation£¨92£© fx;5j;
17£® Transgenic animalת»ùÒò¶¯Î92£© 8U;!1!+
7)
18£® Rb£1£¨92£© _eO] awsA
19£® P53£¨92¡¢91£© k&~vVx
20£® C£jun£¨92£© qL'3MY.!
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© kkJg/:g
22£® °ûÄÚÌ壨99£© i44:VR|
23£® Cyclin dependent kinase inhibitor(CDKI)(99) ze4/XR
24£® G£protein£¨91£© ITsJjcYw
25£® Restriction point£¨91£© <!+o8z]
26£® Antipost£¨91£© {'b8;x8h
27£® Capping£¨91£© t&&OhHK
28£® TATAbox£¨91£© sRMzU
29£® cDNA library£¨90£© 7q\c\qL
30£® Aritotic apparatus£¨90£© nuC K7X
31£® ¿çĤÐźŠtransmembrane signal£¨90£© {$EXI]f
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© S1B/ClKWq
33£® Nuclear lamina£¨90£© R80R{Ze
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£©
.U1dcL6
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© iM956 3v
36£® ϸ°û·Ö»¯£¨00£© A]J^{h0k
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© x$Dv&4
38£® ¿Ë¡£¨00£© 869`jA&7"
39£® »ùÒò×飨00£© T9$U./69-L
40£® Caspase£¨00£© ;+jp,( 7
41£® ת¼Òò×Ó£¨00£© J~}UG]j n
42£® ÅßÌ¥¸Éϸ°û£¨01£© PWmz7*/
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© [D,:=p`
44£® DNAоƬ£¨01£© Stc\P]%d
¶þ¡¢ ÎÊ´ðÌ⣺ w\
mF2h
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© BmM,vllO
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© H|Nw)
*.
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© &-*nr/xT
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© D=\
|teA&
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© (LfVa`<1
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© -hzza1DP
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© Gw./qu-W
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© Qx6/QaS?
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© Lm?*p>\Q
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© A1q^E(}O
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© R\}YD*
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© Z C93C7lJ
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© d.AjH9 jg
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© zFn&~lFB
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© {X$Mwqhpp;
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© wb[(_@eZ
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© 78)^vvn5~
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© ddP,_.0
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© `$
H
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© RuZ;hnE&
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© vR$5ItnT
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© J7GsNFL
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© ra>`J_
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© !P$xh
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© 2[po~}2-0
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© QN
XxpoS#
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© ;#9|l=
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© f'O vG@
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© MjB[5:s
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© )|R9mW=k9P
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© l7,qWSsnK
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© uR@`T18
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© 7[BL 1HI*
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© 3|Sy'J0'K
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©